Skip to content

Michael Levine

6 papers in the library · 98 citations · publishing 1989-2026

Papers

Sort Most recent Most cited

An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder.

medRxiv October 5, 2026 Praachi Tiwari, Sandeep M. Nayak, Nathan D. Sepeda et al. preprint

Importance: Obsessive-Compulsive Disorder (OCD) has a 2% global prevalence, but only about 50% of patients respond to conventional treatment, underscoring the need for additional effective interventions. Objective: To assess the feasibility, safety, and preliminary evidence for efficacy of repeated psilocybin administration in OCD patients who had previously attempted psychotherapy or...

Psychedelic risks and benefits: A cross-sectional survey study.

Journal of Psychopharmacology May 1, 2025 Sean P. Goldy, Benjamin A Du, Julia S Rohde et al. 15 citations

As classic psychedelics' therapeutic potential is studied and their popularity continues to rise, it is important to establish their relative risks and benefits. Previous surveys have tended to use convenience sampling on social media, select participants who have had either extremely positive or negative effects, and have not compared the risk/benefit profile of psychedelics to other...

What is Psychological Support in the Context of Psychedelic Clinical Trials?

Psychedelic Medicine February 7, 2025 Jérémie Richard, Michael Levine 12 citations

The topic of psychological support and psychotherapy in the context of clinical investigations of psychedelic drugs is an often debated, yet predominantly unresolved issue in the field. Psychological support, as a concept, is poorly defined and there appears to be little agreement in the field regarding its essential components, boundaries and limits. While researchers have turned their...

IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.

Pharmacological Research 2024 David B. Yaden, Andrea P Berghella, Peter S. Hendricks et al. 12 citations

Substance use disorders (SUDs) have an enormous impact on public health. With classic psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is possible that these treatments will become legally available options for patients with SUDs in the future. This article highlights how classic psychedelic-assisted therapies might be integrated into current clinical...

Recurrent seizures and serotonin syndrome following "2C-I" ingestion.

Journal of Medical Toxicology June 1, 2013 Adam Bosak, Frank Lovecchio, Michael Levine 59 citations

The phenethylamines, including 2, 5 dimethoxy-4-iodophenethylamine, commonly referred to as 2C-I, have recently emerged as a new class of designer drugs. Cases of toxicity from these drugs are not well described in the literature. This case report describes a 19 year-old male who insufflated 2C-I. Following the ingestion, the patient developed recurrent seizures, and was taken to the emergency...

DOI: 10.1007/s13181-013-0287-x (opens in new tab) Full text (opens in new tab) 2c-i toxicity 2c-i poisoning 2c-i adverse effects 2c-i overdose +14

Mystical Experience and Non–Basically Justified Belief

Religious Studies September 1, 1989 Michael Levine

Two theses are central to foundationalism. First, the foundationalist claims that there is a class of propositions, a class of empirical contingent beliefs, that are ‘immediately justified’. Alternatively, one can describe these beliefs as ‘self–evident’, ‘non–inferentially justified’, or ‘self–warranted’, though these are not always regarded as entailing one another. The justification or...